THE NORTH CENTRAL CANCER TREATMENT GROUP

北中央癌症治疗小组（NCCTG）成立于1999年， 区域集团，但现在有国家成员。 它是 主要是社区诊所， 患者在他们的区域内，通过提供新的和 有希望的临床研究治疗方法。 NCCTG服务于 国家癌症计划的需要，通过生产高质量的 与社区实践最相关的研究 绝大多数的癌症患者 治疗。 政府不合作委员会就建议拨款的具体目的 期间的情况如下： 1. 开展有意义的、科学合理的临床癌症 研究协议。 2. 在临床实践中建立高质量的新标准 研究试验，并以这种方式优化有效性 结果 3. 为了在规划中促进真正的多学科互动， 临床癌症研究的执行和解释 协议. 这种互动将涉及医疗，外科和 放射肿瘤学家、病理学家、统计学家、护士、数据 处理人员以及其他相关的医疗和手术人员 专业和实验室科学家。 4. 评估新癌症治疗的适用性， 社区一级的癌症控制方法， 这个国家的病人都是被管理的 5. 开发最具生产力、互补性和 社区诊所之间的非竞争性互动， 综合癌症中心和国家合作团体。 6. 为了扩大我们的研究视野，超越对 通过探索癌症控制领域， 检测和筛查、症状管理和营养 支持.

The North Central Cancer Treatment Group (NCCTG) was founded at a regional group but now has national membership. It is composed predominantly of community clinics that serve the needs of cancer patients within their regions by providing access to new and hopeful clinical research treatment approaches. The NCCTG serves the needs of the National Cancer Program by producing high quality research that will be most relevant to the community practice setting where the overwhelming majority of cancer patients are treated. The specific aims of the NCCTG over the proposed grant period are the following: 1. To conduct meaningful and scientifically sound clinical cancer research protocols. 2. To set new standards of high quality in the conduct of clinical research trials and in this manner to optimize the validity of results. 3. To foster true multidisciplinary interaction in the planning, execution, and interpretation of clinical cancer research protocols. This interaction will involve medical, surgical and radiation oncologists, pathologists, statisticians, nurses, data handlers, as well as other pertinent medical and surgical subspecialties and laboratory scientists. 4. To evaluate the applicability of new cancer treatment and cancer control approaches at the community level where most cancer patients in this country are managed. 5. To develop the most productive, complimentary and noncompetitive inter-action between community clinics, comprehensive cancer center, and national cooperative groups. 6. To expand our research horizons beyond definitive care of the cancer itself by exploring areas of cancer control including cancer detection and screening, symptomatic management, and nutritional support.